| Title: | ANGPTL4-mediated microglial lipid droplet accumulation: Bridging Alzheimer's disease and obesity |
| Journal: | Neurobiology of Disease |
| Published: | 20 Nov 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39577812/ |
| DOI: | https://doi.org/10.1016/j.nbd.2024.106741 |
Publication 14088
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Increasing evidence suggests that metabolic disorders such as obesity are implicated in the development of Alzheimer's disease (AD). The pathological buildup of lipids in microglia is regarded as a key indicator in brain aging and the progression of AD, yet the mechanisms behind this process remain uncertain. The adipokine ANGPTL4 is strongly associated with obesity and is thought to play a role in the advancement of neurodegenerative diseases. This study utilized RNA sequencing to identify differential expression in lipid-accumulating BV2 microglia and investigated the potential mechanism through ANGPTL4 overexpression in BV2. Subsequently, animal models and clinical data were employed to further explore alterations in circulating ANGPTL4 levels in AD. RNA sequencing results indicated a correlation between ANGPTL4 and microglial lipid accumulation. The overexpression of ANGPTL4 in microglia resulted in increased secretion of inflammatory factors, elevated oxidative stress levels, and diminished antiviral capacity. Furthermore, when simulating the coexistence of AD and obesity through combined treatment with Amyloid-Beta 1-42 peptide (Aβ) and Free Fatty Acids (FFA) in vitro, we observed a notable upregulation of ANGPTL4 expression, highlighting its potential role in the interplay between AD and obesity. In vivo experiments, we also observed a significant increase in ANGPTL4 expression in the hippocampus and plasma of APP/PS1 mice compared to wild-type controls. This was accompanied by heightened microglial activation and reduced expression of longevity-related genes in the hippocampus. Clinical data from the UK Biobank indicated that plasma ANGPTL4 levels are elevated in patients with AD when compared to healthy controls. Moreover, significantly higher ANGPTL4 levels were observed in obese AD patients relative to their non-obese counterparts. Our findings suggest that ANGPTL4-mediated microglial aging may serve as a crucial link between AD and obesity, proposing ANGPTL4 as a potential biomarker for AD.</p>
14 Keywords
- Aged
- Alzheimer Disease
- Amyloid beta-Peptides
- Angiopoietin-Like Protein 4
- Animals
- Female
- Humans
- Lipid Droplets
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Microglia
- Obesity
11 Authors
- Nan Li
- Xiaojun Wang
- Ruilang Lin
- Fuxia Yang
- Hung-Chen Chang
- Xuchao Gu
- Jun Shu
- Guidong Liu
- Yongfu Yu
- Wenshi Wei
- Zhijun Bao
1 Application
| Application ID | Title |
|---|---|
| 98410 | The integration of epidemiological and genomic data to examine the relationship between early life exposure and aging-associated health outcomes later in life |
Enabling scientific discoveries that improve human health